MANNATECH INC Operating Lease Right-of-Use Assets
MANNATECH INC (MTEX) had Operating Lease Right-of-Use Assets of $2.52 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $2.52M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $2.84M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $3.29M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $3.75M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $2.52M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.84M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.29M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.75M 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $1.96M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.09M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $2.53M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.81M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.10M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.31M 10-K · filed 2025-03-26 | $3.30M 10-K · filed 2024-03-28 |
| 2022-12-31 | $4.60M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $4.70M 10-K · filed 2023-03-17 | |
| 2020-12-31 | $6.90M 10-K · filed 2022-03-15 | |
| 2020-03-31 | $5.10M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $5.60M 10-K · filed 2021-03-19 | |
| 2019-06-30 | $5.70M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $4.80M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |